Cancer DNA in the circulation: The liquid biopsy

JAMA - Journal of the American Medical Association

Volumn 318, Issue 13, 2017, Pages 1272-1273

  Husain, Hatim ^a   Velculescu, Victor E ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CIRCULATING TUMOR DNA; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BRAF GENE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER RESISTANCE; CELL SURVIVAL; COPY NUMBER VARIATION; DNA DETERMINATION; EGFR GENE; EVIDENCE BASED MEDICINE; EXOME; GENE AMPLIFICATION; GENE MUTATION; GENE REARRANGEMENT; GENETIC VARIABILITY; LIMIT OF DETECTION; LIQUID BIOPSY; MOLECULAR DIAGNOSIS; NEXT GENERATION SEQUENCING; NON INVASIVE PROCEDURE; NON SMALL CELL LUNG CANCER; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT RESPONSE; BIOPSY; BLOOD; DNA SEQUENCE; GENETICS; HUMAN; NEOPLASMS; PROCEDURES;

BIOPSY; DNA, NEOPLASM; HUMANS; NEOPLASMS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 85031318154     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2017.12131     Document Type: Article

References (10)

1. Mandel P, Metais P. Les acides nucléiques du plasma sanguin chez l'homme. C R Seances Soc Biol Fil. 1948;142(3-4):241-243.
2. Sidransky D. Nucleic acid-based methods for the detection of cancer. Science. 1997;278(5340):1054-1059.
3. Kinde I, Wu J, Papadopoulos N, Kinzler KW, Vogelstein B. Detection and quantification of rare mutations with massively parallel sequencing. Proc Natl Acad Sci U S A. 2011;108(23):9530-9535.
4. Newman AM, Bratman SV, To J, et al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat Med. 2014;20(5):548-554.
5. Phallen J, Sausen M, Adleff V, et al Direct detection of early-stage cancers using circulating tumor DNA. Sci Transl Med. 2017;9(403), eaan2415.
6. Evans JP, Powell BC, Berg JS. Finding the rare pathogenic variants in a human genome. JAMA. 2017;317(18):1904-1905.
7. Leary RJ, Sausen M, Kinde I, et al. Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing. Sci Transl Med. 2012;4(162):162ra154.
8. Vogelstein B, Kinzler KW. Digital PCR. Proc Natl Acad Sci U S A. 1999;96(16):9236-9241.
9. Oxnard GR, Paweletz CP, Kuang Y, et al. Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA. Clin Cancer Res. 2014;20(6):1698-1705.
10. US Food and Drug Administration. Cobas EGFR mutation test v2-P150047. https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm504540.htm. Accessed September 17, 2017.